Clinical & Diagnostic
Doer Biologics Begins Phase 2 Study of First-in-Class Tri-Agonist DR10624 for Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...
October 01, 2024 | News
Thermo Fisher Scientific Expands Global Reach with Launch of CorEvitas Adolescent Atopic Dermatitis Registry
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis ...
October 01, 2024 | News
Belief BioMed and AskBio Forge Strategic Collaboration to Advance Liver-Targeted Gene Therapies
Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach...
September 26, 2024 | News
Veltassa® Secures Approval in Japan for Hyperkalemia Management in CKD and Heart Failure Patients
Veltassa® offers effective and well-tolerated long-term potassium control in chronic kidney disease and chronic heart failure patients 1-5 Z...
September 25, 2024 | News
BioCina Partners with EnGeneIC to Accelerate Manufacturing of Cutting-Edge Cancer Treatment
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with drug deve...
September 25, 2024 | News
The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
This is especially concerning in Asia, where rates of illness are expected to rise in the coming years. When it comes to breast cancer, for instance, Asia ...
September 20, 2024 | Opinion | By Deepti Saraf General Manager, Roche (Malaysia) Sdn. Bhd.
Hyphens Pharma Introduces Ceradan® Advanced Hand Balm: A New Solution for Hand Eczema
Hyphens Pharma International Limited (“Hyphens Pharma”, “凯帆药剂国际有限公司”, or the “Company”, and t...
September 19, 2024 | News
Full-Life Technologies Secures $571.5M Licensing Deal with SK Biopharmaceuticals for Anti-Cancer Radiopharmaceutical FL-091
Full-Life Technologies seals $571.5 million agreement with SK Biopharmaceuticals to license and further develop Full-Life's 'FL-091' ra...
September 19, 2024 | News
Singapore Becomes First Southeast Asian Market to Launch BESREMi®️, Setting a New Standard for Rare Disease Care
PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator specializing in haematology and oncology, proudly announces the launch of BES...
September 17, 2024 | News
Coya Therapeutics Demonstrates Promising CNS Anti-Inflammatory Effects of COYA 302 in Parkinson’s Disease Model
A key aspect of Parkinson’s disease (PD) pathophysiology is decreased systemic regulatory T cell (Treg) function with associated neuroinflammat...
September 17, 2024 | News
Johnson & Johnson’s TAR-200 Shows Promising Results in BCG-Unresponsive Bladder Cancer in Latest Phase 2b SunRISe-1 Study
Johnson & Johnson announced additional results from its pivotal Phase 2b SunRISe-1 study, reinforcing the safety and efficacy of TAR-200, an investigat...
September 16, 2024 | News
ImmVira Reports Promising Phase I Results for Oncolytic Virus MVR-T3011 in BCG-Failure Bladder Cancer
ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk B...
September 16, 2024 | News
Genea Biomedx Joins Basecare Medical to Drive Global Expansion of Assisted Reproductive Technology
Genea Biomedx, which was once part of Genea Fertility, joined the Basecare Medical group in 2023 with the aim of distributing Basecare's assisted reproduct...
September 13, 2024 | News
Nona Biosciences and Umoja Biopharma Partner to Advance Next-Generation CAR-T Cell Therapies
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced that it has entered into a multi...
September 13, 2024 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
